KIMS Approves Q2 Results, Key Reappointments, and Subsidiary Merger
Krishna Institute of Medical Sciences Ltd 路 Outcome 路 05 Nov 2026, 12:17 am
KIMS Approves Q2 Results, Key Reappointments, and Subsidiary Merger Krishna Institute of Medical Sciences (KIMS) approved unaudited financial results for the quarter ended 30th Sep'26, posting consolidated revenue from operations of Rs. 13,444 million and net profit of Rs. 746 million. The board cleared the merger of wholly-owned subsidiary KIMS Hospitals Pvt Ltd into the parent company. Additionally, KIMS Swastha entered an O&M agreement for Westfort Hospital, Thrissur. Dr. Bhaskara Rao Bollineni (CMD) and Dr. Abhinay Bollineni (Director & CEO) were reappointed for five-year terms. KIMS also acquired a 51% stake in Sarvottam Health Care for Rs. 795 million.
Original exchange filing (PDF)
More announcements from Krishna Institute of Medical Sciences Ltd
- O & M Agreement 路 14 Nov 2026
- Transcript of Investor call held on 05.11.2026 路 11 Nov 2026
- Investec Pune Confluence 路 10 Nov 2026
- Avendus Spark INDX: Annual Investor Conference 路 10 Nov 2026
- Audio Call Link 路 06 Nov 2026
- Deviation Report - QIP 路 05 Nov 2026
- Deviation Report - Preferential Allotment 路 05 Nov 2026
- Preferential Allotment - Monitoring Agency Report 路 05 Nov 2026
